PharmaMedic /
  • Home
  • Our Services
    • Start-Up
    • Product Launch
    • Product Development
  • Join Us
  • About Us
    • Our Vision
    • Dr Malcolm Barratt-Johnson
  • Resources
  • News
  • Contact Us
PharmaMedic
  • Home
  • Our Services
    • Start-Up
    • Product Launch
    • Product Development
  • Join Us
  • About Us
    • Our Vision
    • Dr Malcolm Barratt-Johnson
  • Resources
  • News
  • Contact Us

#R&D

Tag

Award for PharmaMedic’s Managing Director

Award for PharmaMedic’s Managing Director

We are excited to report that PharmaMedic's Managing Director, Dr Malcolm Barratt-Johnson has received a Global Fellow in Medicines Development (GFMD) award from the respected GMDP Academy.

1 Jun 2023
Read More
US FDA issues draft guidance on decentralised clinical trials

US FDA issues draft guidance on decentralised clinical trials

Decentralised clinical trials (DCTs) are being used increasingly in the pharma industry for clinical research and the US Food and Drug Administration (FDA) has published draft guidance for those carrying out trials at non-traditional investigation sites.

18 May 2023
Read More
New Integrated Pathology Unit to speed cancer diagnosis

New Integrated Pathology Unit to speed cancer diagnosis

Cancer diagnosis and treatment are set to be accelerated with the opening of England’s first Integrated Pathology Unit (IPU). The new facility will apply pioneering digital imaging and artificial intelligence to pathology, assisting clinical trial research programmes focused on developing tests for cancer.

17 May 2023
Read More
The 2023 ABPI annual conference focused on growing the Life Sciences

The 2023 ABPI annual conference focused on growing the Life Sciences

The 2023 annual conference of the UK’s Association of the British Pharmaceutical Industry (ABPI) at the end of April had a theme of Growing the UK as a Global Hub for Life Sciences.

9 May 2023
Read More
Backing innovation in British biotechnology

Backing innovation in British biotechnology

What is the future for UK-based biotechnology? This article reviews the financing of, and governmental support for, the sector and considers the potential impact of new technology in the development of the life sciences.

2 May 2023
Read More
Pioneer plan to support UK research if Horizon Europe talks fail

Pioneer plan to support UK research if Horizon Europe talks fail

While the UK science sector remains committed to association with the international research programme Horizon Europe, the British government has announced its own alternative, which would be implemented if negotiations falter.

13 Apr 2023
Read More
Support for Life Sciences in UK Spring Budget 2023

Support for Life Sciences in UK Spring Budget 2023

The UK’s Spring Budget, announced on 15 March 2023, set out the government’s plans to help businesses, including the life sciences sector. In addition to an enhanced rate of tax relief for loss-making R&D-focused small and medium sized enterprises, companies investing in qualifying main rate plant and machinery can write off the full cost from 1 April 2023 until 31 March 2026 under a 100% First Year Allowance. Read the full Spring Budget.

22 Mar 2023
Read More
Windsor Framework returns NI medicines control to UK

Windsor Framework returns NI medicines control to UK

The recently announced Windsor Framework seeks to restore Northern Ireland’s position as part of the UK and thereby undo the political, economic and societal challenges brought about by two years under the Northern Ireland Protocol. As over 1,700 pages of EU law will no longer apply in the region, what will be the situation for medicines supply once the deal goes through, and how will greater cooperation with the EU impact research and innovation under Horizon Europe?

20 Mar 2023
Read More
UK government launches Science and Technology Framework

UK government launches Science and Technology Framework

As part of its plan to make the UK a science and technology superpower by 2030, the government launched its ‘Science and Technology Framework’ on 6 March 2023.

16 Mar 2023
Read More
BIA reassured by Chancellor on life science support

BIA reassured by Chancellor on life science support

The UK BioIndustry Association (BIA) appears to have won a reprieve on proposed cuts to SME R&D tax credits, via a letter from Chancellor Jeremy Hunt. The policy was introduced in the Government’s Autumn Statement in November 2022, due to take effect in April 2023.

12 Jan 2023
Read More

Categories

  • Awards
  • Consultants
  • Events
  • News
    • General
    • Medical Affairs
    • Rare diseases
  • Our Services
  • Regulatory
  • Resources
    • White Paper

Tags

#ABPI #BIA #cancer #ClinicalTrials #diagnostics #drugdevelopment #drugpricing #drugregulation #EC #EFPIA #EMA #EU #FDA #HTA #innovation #lifesciences #marketaccess #MDR #medicaldevice #medicaldeviceregulation #medicinesaccess #medtech #mentalhealth #mhra #NHS #NICE #pharmaregulation #pre-eclampsia #R&D #rarediseases #regulation #regulatory #research #UKgovernment #ukregulation #VPAS AI Biotech COVID-19 Healthcare IR35 Medical Affairs medicaldevices Pharma UKmedicines
PharmaMedic
  • Home
  • Join Us
  • Our Vision
  • Dr Malcolm Barratt-Johnson
  • Resources
  • News
  • Contact Us
Our Services
  • Start-Up
  • Product Launch
  • Product Development
Legal
  • Privacy Policy
  • Cookie Policy
Contact us
  • T:+44 (0) 208 168 1668
  • US Toll Free:+1 628 201 0911
  • [javascript protected email address]
  • The London Bioscience Innovation Centre (LBIC)
    2 Royal College Street
    London NW1 0NH

©2023 PharmaMedic. All Rights Reserved | Company Registration Number: 07364364 | VAT: 135986768

Powered by FL1 Digital